Databean

Databean

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Founded in 2015, Databean is a US-based CRO that provides end-to-end clinical trial services to innovative medtech and biotech startups. It differentiates itself through deep domain knowledge in areas like solid organ transplantation, a collaborative approach tailored to startup dynamics, and a proprietary cloud-based platform called TrialPoint™ for operational efficiency. The company operates as a private, revenue-generating services business, helping clients navigate regulatory pathways and achieve cost-effective, timely trial execution from first-in-human studies to post-market surveillance.

Chronic Health ConditionsSolid Organ Transplantation

Technology Platform

Proprietary cloud-based clinical trial management and data operations platform called TrialPoint™, designed to streamline operational and data management tasks for improved efficiency.

Opportunities

The growing trend of R&D outsourcing by capital-efficient biotech/medtech startups creates a strong demand for niche, expert CROs.
The expansion of digital health and novel trial designs presents an opportunity to leverage the TrialPoint™ platform and specialized expertise to serve an evolving market segment.

Risk Factors

Revenue is highly dependent on the funding environment for life science startups, which is cyclical.
The company faces intense competition from large, global CROs and other niche providers, requiring constant demonstration of superior value.

Competitive Landscape

Databean competes in the fragmented global CRO market, against large players (e.g., IQVIA, ICON, PPD) and many small-to-mid-sized specialists. Its differentiation lies in its focused collaboration with startups, deep therapeutic expertise in complex areas like transplantation, and its proprietary TrialPoint™ operational platform.